Cinryze® [C1 esterase inhibitor (human)]
| Full Name | Cinryze® [C1 esterase inhibitor (human)] |
| Drug | Cinryze |
| Manufacturer | Takeda Pharmaceuticals U.S.A., Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Routine prophylaxis against angioedema attacks in adults, adolescents, and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE) |
| Disease | Hereditary Angioedema (HAE) |
| Therapeutic Area | Allergy & Immunology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-356-4252 |
| Fax Number | 847-631-6918 |
| Product Website | cinryze.com/hcp |
| Patient Resources | HAEA |